Viewing Study NCT05831033


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2025-12-26 @ 1:40 AM
Study NCT ID: NCT05831033
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2023-04-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module